Stratified Mucin-Producing Intraepithelial Lesion of the Cervix in an HPV-16 Positive Woman: A Rare Encounter

Article ID: e290124226396 Pages: 5

  • * (Excluding Mailing and Handling)

Abstract

Background: Cervical cancer is the fourth most common cancer among women globally and has a strong association with Human Papillomavirus (HPV) infection. Stratified mucinproducing intraepithelial lesion (SMILE), a variant of Adenocarcinoma in situ (AIS), is a rare cervical precancer lesion that is often missed or detected incidentally.

Case Presentation: The present case report briefs the finding of a 39-year-old woman who presented to the gynecological outpatient department with complaints of vaginal discharge for 6-8 months. She had no history of irregular menstrual cycles or postcoital bleeding. Her routine Pap smear revealed atypical squamous cells of undetermined significance (ASCUS) and was positive for HPV-16 type. Her cervical biopsy report revealed AIS and her histopathological report of hysterectomy revealed SMILE, a variant of AIS.

Discussion: The SMILE variant of AIS is a rare cervical precancerous lesion characterized by the morphological overlap of both squamous intraepithelial lesions and AIS. It is often difficult to diagnose on Pap smear and is commonly associated with high-risk HPV infections. The management of SMILE is the same as that for AIS, which is the excisional procedure followed by a hysterectomy if the margins are negative and depending on the fertility desires of the patient, followed by regular follow-up with HPV testing.

Conclusion: SMILE is a rare variant of AIS, which is often missed on cytological screening of the cervix. It is commonly associated with high-risk types of HPV. Hence, incorporating HPV testing in the screening of cervical cancer is important and recommended to increase the overall sensitivity of screening for adenocarcinoma lesions.

[1]
World Health Organization Cervical Cancer, Fact sheet. 2022. Available from: https://www.who.int/news-room/fact-sheets/detail/cervical-cancer
[2]
Okunade KS. Human papillomavirus and cervical cancer. J Obstet Gynaecol 2020; 40(5): 602-8.
[http://dx.doi.org/10.1080/01443615.2019.1634030 ] [PMID: 31500479]
[3]
GLOBOCAN 2012 database. Cervical Cancer: Estimated Incidence, Mortality and Prevalence Worldwide. International Agency for Research on Cancer 2012.
[4]
Adegoke O, Kulasingam S, Virnig B. Cervical cancer trends in the United States: A 35-year population-based analysis. J Womens Health 2012; 21(10): 1031-7.
[http://dx.doi.org/10.1089/jwh.2011.3385 ] [PMID: 22816437]
[5]
Cleveland AA, Gargano JW, Park IU, et al. Cervical adenocarcinoma in situ: Human papillomavirus types and incidence trends in five states, 2008–2015. Int J Cancer 2020; 146(3): 810-8.
[http://dx.doi.org/10.1002/ijc.32340 ] [PMID: 30980692]
[6]
Munro A, Codde J, Spilsbury K, et al. Risk of persistent and recurrent cervical neoplasia following incidentally detected adenocarcinoma in situ. Am J Obstet Gynecol 2017; 216(3): 272.e1-7.
[http://dx.doi.org/10.1016/j.ajog.2016.11.1044 ] [PMID: 27908632]
[7]
Hodgson A, Parra-Herran C. SMILE (stratified mucin-producing intraepithelial lesions). Available from: https://www.pathologyoutlines.com/topic/cervixSMILE.html (Accessed September 26th, 2023).
[8]
Bellamkonda V, Avalos Hernandez SR. Stratified Mucin Producing Intraepithelial Lesion (SMILE): Report of two cases. Am J Clin Pathol 2020; 154(S1): S41.
[http://dx.doi.org/10.1093/ajcp/aqaa161.086]
[9]
Lax SF, Horn LC, Löning T. [Categorization of uterine cervix tumors: What's new in the 2014 WHO classification]. Pathologe 2016; 37(6): 573-84.
[http://dx.doi.org/10.1007/s00292-016-0247-8]
[10]
Strojan Fležar M, Nedelko N, Poljak M. Oštrbenk Valenčak A, Gutnik H. Stratified Mucin-Producing Intraepithelial Lesion (SMILE) of the uterine cervix: High-Risk HPV genotype predominance and p40 immunophenotype. Cells 2021; 10(8): 2039.
[http://dx.doi.org/10.3390/cells10082039 ] [PMID: 34440808]
[11]
Schwock J, Ko HM, Dubé V, et al. Stratified mucin-producing intraepithelial lesion of the cervix: Subtle features not to be missed. Acta Cytol 2016; 60(3): 225-31.
[http://dx.doi.org/10.1159/000447940 ] [PMID: 27442040]
[12]
Lastra RR, Park KJ, Schoolmeester JK. Invasive stratified mucin-producing carcinoma and Stratified Mucin-producing Intraepithelial Lesion (SMILE). Am J Surg Pathol 2016; 40(2): 262-9.
[http://dx.doi.org/10.1097/PAS.0000000000000543 ] [PMID: 26523540]
[13]
Fukui S, Nagasaka K, Iimura N, et al. Detection of HPV RNA molecules in stratified mucin-producing intraepithelial lesion (SMILE) with concurrent cervical intraepithelial lesion: A case report. Virol J 2019; 16(1): 76.
[http://dx.doi.org/10.1186/s12985-019-1180-2] [PMID: 31159808]
[14]
Ohta Y, Kunimura T, Omatsu M, Shiokawa A, Kushima M, Ota H. Mixed mucin-producing and squamous differentiated tumor of the uterine cervix: A report of a case as adenosquamous carcinoma in situ. J Obstet Gynaecol Res 2013; 39(1): 420-3.
[http://dx.doi.org/10.1111/j.1447-0756.2012.01904.x ] [PMID: 23294292]
[15]
Schiffman M, Wentzensen N. Human papillomavirus infection and the multistage carcinogenesis of cervical cancer. Cancer Epidemiol Biomarkers Prev 2013; 22(4): 553-60.
[http://dx.doi.org/10.1158/1055-9965.EPI-12-1406 ] [PMID: 23549399]
[16]
Backhouse A, Stewart CJR, Koay MHE, et al. Cytologic findings in stratified mucin-producing intraepithelial lesion of the cervix: A report of 34 cases. Diagn Cytopathol 2016; 44(1): 20-5.
[http://dx.doi.org/10.1002/dc.23381 ] [PMID: 26493276]
[17]
Onishi J, Sato Y, Sawaguchi A, et al. Stratified mucin-producing intraepithelial lesion with invasive carcinoma: 12 cases with immunohistochemical and ultrastructural findings. Hum Pathol 2016; 55: 174-81.
[http://dx.doi.org/10.1016/j.humpath.2016.05.007 ] [PMID: 27237368]
[18]
Boyle DP, McCluggage WG. Stratified mucin-producing intraepithelial lesion (SMILE): Report of a case series with associated pathological findings. Histopathology 2015; 66(5): 658-63.
[http://dx.doi.org/10.1111/his.12498 ] [PMID: 25039487]
[19]
Hill EK. Management of Adenocarcinoma in situ of the cervix (AIS) ASCCP 2020-2021 Practice Committee. 2021. Available from: https://www.asccp.org/pearl-ais
[20]
Teoh D, Musa F, Salani R, Huh W, Jimenez E. Diagnosis and management of adenocarcinoma in situ. Obstet Gynecol 2020; 135(4): 869-78.
[http://dx.doi.org/10.1097/AOG.0000000000003761 ] [PMID: 32168211]